Zenth Health Sciences

Engineering the Future of
Biological Possibility

From gene-editing breakthroughs to AI-driven diagnostics, our Health Sciences division is pioneering the next era of human longevity, disease eradication, and medical accessibility across the globe.

Core Research Pillars

Our multidisciplinary approach integrates biology, data science, and advanced engineering to solve humanity's most complex health challenges.

Pharmaceutical R&D

Developing next-generation therapeutics using AI-accelerated drug discovery platforms, targeting orphan diseases, oncology, and neurodegenerative conditions.

AI Drug Design Oncology Neuro
🦷

Gene Editing & CRISPR

Pioneering precision genome engineering therapies for hereditary disorders, leveraging proprietary delivery mechanisms and safety protocols.

CRISPR-Cas Gene Therapy Ethics
🔍

MedTech & Devices

Manufacturing advanced medical devices, minimally invasive surgical robots, implantable biosensors, and lab-on-chip diagnostics.

Surgical Robotics Biosensors Imaging
🌐

Global Telemedicine

Operating ZenthCare Network, a decentralized telemedicine infrastructure providing expert consultation and remote monitoring in underserved regions.

Remote Care AI Triage Access

Active Breakthroughs

Tracking our pipeline of transformative research and clinical trials.

Q4 2026

Project Aeterna: Cellular Senescence Reversal

Clinical trial demonstrating significant reduction in senescent cell burden and tissue rejuvenation metrics in human subjects.

Phase 3
Q3 2026

NeuroLink 4.0 Interface

Non-invasive brain-computer interface achieving >99% accuracy in motor intent decoding for paralysis rehabilitation.

Launched
Q2 2026

OncoZenth CAR-T Automation

Fully automated bioreactor system for personalized CAR-T cell therapy production, reducing lead time from weeks to days.

Phase 2
Q1 2026

Zenth-Vax Universal Platform

mRNA-based modular vaccine platform capable of rapid reconfiguration against emerging viral pathogens.

Approved

Impact at Scale

1,240+
Active Clinical Trials
45
FDA/EMA Approvals
$8.4B
Annual R&D Spend
140M
Patients Reached

Collaborate with Zenth Health

Whether you are a research institution, biotech startup, or healthcare provider, explore partnership opportunities to accelerate the future of medicine.